Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
The British Journal of Dermatology|November 1, 1989
Novel variants of human papillomavirus type 2 in warts from immunocompromised individualsC A Wilson, S C Holmes, M S Campo, et al.
The British Journal of Dermatology|February 1, 1987
Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up studyN H Cox, S K Jones, D J Downey, et al.
BMJ (Clinical Research Ed.)|September 10, 1988
Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanomaA J Swerdlow, J S English, R M MacKie, et al.
BMJ (Clinical Research Ed.)|December 31, 1997
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma GroupR M MacKie, D Hole, J A Hunter, et al.
British Medical Journal (Clinical Research Ed.)|January 17, 1987
Relation between phenotype and banal melanocytic naeviJ S English, A J Swerdlow, R M MacKie, et al.
The British Journal of Dermatology|May 1, 1988
Site-specific melanocytic naevus counts as predictors of whole body naeviJ S English, A J Swerdlow, R M Mackie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Utility of adjuvant systemic therapy in melanomaA M M Eggermont, A Testori, J Marsden, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusionR N Scott, R Blackie, D J Kerr, et al.
Genes, Chromosomes & Cancer|July 1, 1993
Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancersI P Tomlinson, A J Gammack, J E Stickland, et al.
British Journal of Cancer|July 1, 1992
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanomaR N Scott, D J Kerr, R Blackie, et al.
Pageof 19